Product Images Ondansetron
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 3 images provide visual information about the product associated with Ondansetron NDC 16714-159 by Northstar Rx Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 4 mg Blister Carton (10 x 10 Unit-dose) - ondansetron fig1
Each tablet of this medicine contains Ondansetron hydrochloride USP as its active ingredient. It is manufactured by Aurobindo Pharma Limited in Hyderabad, India, for Northstar Rx LLC, a subsidiary of Nortstar Healthcare Holdings. The medicine is used for the prevention of nausea and vomiting caused by cancer chemotherapy, radiation therapy, and surgery. The recommended dosage is mentioned in the package insert. The tablets should be stored in a tightly closed container at a temperature between 20°C and 25°C, protected from light. This information was last updated in March 2021.*
PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 8 mg (500 Tablet Bottle) - ondansetron fig2
Each tablet of this medication contains ondansetron hydrochloride and is manufactured by Aurobindo Pharma Limited. The usual dosage should be followed as per the instructions provided in the package insert. The tablets should be stored in a light-resistant container and protected from light. The medication is distributed by Northstar Rx LLC and dispensed in an 8 mg container. The NDC for this medication is 16714-160-01. This information is valid as of March 2021.*
Chemical Structure - ondansetron str
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.